OBJECTIVE: To assess the direct cost during hospitalization for an osteoporotic hip fracture in Brazilian private health care system, by health plan companies' perspective. METHODS: We conducted a cross-sectional and retrospective study on costs of medical resources in patients above 50 years with an osteoporotic hip fracture, under hospital treatment, between July 2003 and June 2004. The study sample was collected from electronic claims databases of patients enrolled in Brazilian health plans. RESULTS: There were 129,611 patients with osteoporosis diagnosis. The incidence of osteoporotic hip fracture was 4.99% (women). The mean length of hospital stay was 9.21 days (2.13 days in ICU). The total mean cost of hospitalization was R$ 24,000. The largest cost component was attributable to medical device (61%). The economic burden of osteoporotic hip fracture to health plan companies was estimated in R$ 12 million. CONCLUSION: The costs of treating osteoporotic hip fracture are substantial in Brazilian private health care system. This study highlights the savings to health plan companies if an osteoporotic hip fracture can be avoided.
OBJECTIVE: To assess the direct cost during hospitalization for an osteoporotic hip fracture in Brazilian private health care system, by health plan companies' perspective. METHODS: We conducted a cross-sectional and retrospective study on costs of medical resources in patients above 50 years with an osteoporotic hip fracture, under hospital treatment, between July 2003 and June 2004. The study sample was collected from electronic claims databases of patients enrolled in Brazilian health plans. RESULTS: There were 129,611 patients with osteoporosis diagnosis. The incidence of osteoporotic hip fracture was 4.99% (women). The mean length of hospital stay was 9.21 days (2.13 days in ICU). The total mean cost of hospitalization was R$ 24,000. The largest cost component was attributable to medical device (61%). The economic burden of osteoporotic hip fracture to health plan companies was estimated in R$ 12 million. CONCLUSION: The costs of treating osteoporotic hip fracture are substantial in Brazilian private health care system. This study highlights the savings to health plan companies if an osteoporotic hip fracture can be avoided.
Authors: Agnaldo S Cruz; Hertz C Lins; Ricardo V A Medeiros; José M F Filho; Sandro G da Silva Journal: Biomed Eng Online Date: 2018-01-29 Impact factor: 2.819
Authors: Ednei Fernando Dos Santos; Maria Rita Aprile; Angelica Castilho Alonso; Luis Eugênio Garcez-Leme; Julia Maria D'Andréa Greve Journal: Acta Ortop Bras Date: 2015 Jul-Aug Impact factor: 0.513
Authors: Daniela Cardeal da Silva Chaba; Lisméia R Soares; Rosa M R Pereira; George W Rutherford; Tatiane Assone; Liliam Takayama; Luiz A M Fonseca; Alberto J S Duarte; Jorge Casseb Journal: Rev Inst Med Trop Sao Paulo Date: 2017-12-21 Impact factor: 1.846
Authors: Bruno de Melo Pinheiro; Antônio Luiz Pereira de Siqueira Campos; Dionísio Dias Aires de Carvalho; Agnaldo Souza Cruz; Ricardo Alexsandro de Medeiros Valentim; Nicolas Vinícius Rodrigues Veras; João Paulo Queiroz Dos Santos Journal: Sci Rep Date: 2021-09-27 Impact factor: 4.379